Early Antiretroviral Therapy in South African Children Reduces HIV-1-Infected Cells and Cell-Associated HIV-1 RNA in Blood Mononuclear Cells
Open Access
- 23 December 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 212 (1) , 39-43
Abstract
We measured cell-associated human immunodeficiency virus (HIV)-1 DNA (CAD) and RNA (CAR) and plasma HIV-1 RNA in blood samples from 20 children in the Children with HIV Early Antiretroviral (CHER) cohort after 7–8 years of suppressive combination antiretroviral therapy (cART). Children who initiated cART early (P < .01) and CAR (median, 5 vs 436; P < .01) per million peripheral blood mononuclear cells than children who started later (≥2 months; n = 8). Plasma HIV-1 RNA levels were not significantly lower in early-treated children (0.5 vs 1.2 copies/mL; P = .16). Early treatment at <2 months of age reduces the number of HIV-infected cells and HIV CAR.Keywords
This publication has 15 references indexed in Scilit:
- Early Initiation of Combination Antiretroviral Therapy in HIV-1-Infected Newborns Can Achieve Sustained Virologic Suppression With Low Frequency of CD4+ T Cells Carrying HIV in Peripheral BloodClinical Infectious Diseases, 2014
- HIV Type 1 (HIV-1) Proviral Reservoirs Decay Continuously Under Sustained Virologic Control in HIV-1–Infected Children Who Received Early TreatmentThe Journal of Infectious Diseases, 2014
- Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in childrenAIDS, 2014
- Quantification of HIV-1 latency reversal in resting CD4 + T cells from patients on suppressive antiretroviral therapyProceedings of the National Academy of Sciences, 2014
- Lack of Detectable HIV-1 Molecular Evolution during Suppressive Antiretroviral TherapyPLOS Pathogens, 2014
- Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trialThe Lancet, 2013
- Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeysNature, 2013
- Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 CureCell, 2013
- Plasma Viremia and Cellular HIV-1 DNA Persist Despite Autologous Hematopoietic Stem Cell Transplantation for HIV-Related LymphomaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2013
- Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI StudyPLOS Pathogens, 2013